Reference health
Prevalence of cognitive impairment and change in patients with breast cancer: A systematic review of longitudinal studies
78/78 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
1 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 78 checked references that resolve
resolves10.3322/caac.21492
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
resolves10.7812/TPP/14-241
Breast Cancer Survivorship: A Comprehensive Review of Long-Term Medical Issues and Lifestyle Recommendations
resolves10.1002/pon.3163
Cognitive effects of chemotherapy in breast cancer patients: a dose–response study
resolves10.1093/jnci/90.3.210
Impairment of Cognitive Function in Women Receiving Adjuvant Treatment for High-Risk Breast Cancer: High-Dose Versus Standard-Dose Chemotherapy
resolves10.1002/pon.4190
Objective–subjective disparity in cancer‐related cognitive impairment: does the use of change measures help reconcile the difference?
resolves10.1080/13548506.2018.1500023
Women’s experiences of cancer-related cognitive impairment, its impact on daily life and care received for it following treatment for breast cancer
resolves10.1177/2055102919832234
‘A new normal with chemobrain’: Experiences of the impact of chemotherapy-related cognitive deficits in long-term breast cancer survivors
resolves10.1200/JCO.2011.39.5640
Meta-Analysis of Cognitive Functioning in Breast Cancer Survivors Previously Treated With Standard-Dose Chemotherapy
resolves10.4048/jbc.2012.15.4.454
Unmet Needs and Their Relationship with Quality of Life among Women with Recurrent Breast Cancer
resolves10.5014/ajot.2016.018101
Toward a Broader Role for Occupational Therapy in Supportive Oncology Care
resolves10.1002/pon.1673
Subjective cognitive dysfunction in breast cancer patients: a systematic review
resolves10.1080/138540491005875
A Meta-Analysis of the Neuropsychological Effects of Adjuvant Chemotherapy Treatment in Women Treated for Breast Cancer
resolves10.1016/j.bandc.2005.05.001
The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: A meta-analysis of the current literature
resolves10.1016/j.neubiorev.2017.10.028
Cognitive impairment in breast cancer survivors treated with chemotherapy depends on control group type and cognitive domains assessed: A multilevel meta-analysis
resolves10.1007/s40261-015-0364-9
The Impact of Endocrine Therapy on Cognitive Functions of Breast Cancer Patients: A Systematic Review
resolves10.1007/s10549-016-3906-9
Endocrine treatment-associated cognitive impairment in breast cancer survivors: evidence from published studies
resolves10.1002/cam4.174
Association between adjuvant regional radiotherapy and cognitive function in breast cancer patients treated with conservation therapy
resolves10.1016/j.ijrobp.2010.06.037
One-Year Longitudinal Study of Fatigue, Cognitive Functions, and Quality of Life After Adjuvant Radiotherapy for Breast Cancer
resolves10.1007/s10549-008-0114-2
Cognitive impairments associated with breast cancer treatments: results from a longitudinal study
resolves10.1200/JCO.2002.20.2.485
Neuropsychologic Impact of Standard-Dose Systemic Chemotherapy in Long-Term Survivors of Breast Cancer and Lymphoma
resolves10.1002/hbm.21102
Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer
resolves10.1176/jnp.2010.22.1.48
Neuropsychological Outcomes of Older Breast Cancer Survivors: Cognitive Features Ten or More Years After Chemotherapy
resolves10.1002/cncr.25098
Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer
resolves10.1007/s00520-010-0997-4
A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients
resolves10.1200/JCO.2016.68.5826
Cognitive Complaints in Survivors of Breast Cancer After Chemotherapy Compared With Age-Matched Controls: An Analysis From a Nationwide, Multicenter, Prospective Longitudinal Study
resolves10.1002/cncr.20272
The cognitive sequelae of standard‐dose adjuvant chemotherapy in women with breast carcinoma
resolves10.1016/j.breast.2004.10.004
The effects of adjuvant chemotherapy on cognition in women with breast cancer—preliminary results of an observational longitudinal study
resolves10.1002/pon.1379
Cognitive effects of chemotherapy in post‐menopausal breast cancer patients 1 year after treatment
resolves10.1002/pon.1210
The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study
resolves10.1002/pon.1342
Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide
resolves10.1002/pon.1595
The impact of different definitions and reference groups on the prevalence of cognitive impairment: a study in postmenopausal breast cancer patients before the start of adjuvant systemic therapy
resolves10.1093/jnci/djj470
Change in Cognitive Function After Chemotherapy: a Prospective Longitudinal Study in Breast Cancer Patients
resolves10.1111/j.1532-5415.2006.00732.x
Cognitive Function of Older Patients Receiving Adjuvant Chemotherapy for Breast Cancer: A Pilot Prospective Longitudinal Study
resolves10.3389/fnhum.2017.00555
Predicting Long-Term Cognitive Outcome Following Breast Cancer with Pre-Treatment Resting State fMRI and Random Forest Machine Learning
resolves10.1111/j.1743-7563.2007.00109.x
Prospective evaluation of cognitive function in patients with early breast cancer receiving adjuvant chemotherapy
resolves10.1007/s10549-006-9383-9
Is cognitive dysfunction a complication of adjuvant chemotherapy in the older patient with breast cancer?
resolves10.1093/annonc/mdf241
Late effects of adjuvant chemotherapy on cognitive function:a follow-up study in breast cancer patients
resolves10.1093/jnci/djx057
Chemotherapy and Post-traumatic Stress in the Causation of Cognitive Dysfunction in Breast Cancer Patients
resolves10.1016/j.jpainsymman.2016.04.012
Cognitive Impairment in a Subset of Breast Cancer Patients After Systemic Therapy—Results From a Longitudinal Study
resolves10.1017/S1355617713001215
Persistent Cognitive Changes in Breast Cancer Patients 1 Year Following Completion of Chemotherapy
resolves10.1007/s10549-010-0756-8
Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study
resolves10.1038/sj.bjc.6603029
A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer
resolves10.1002/pon.1398
No indications of cognitive side‐effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy
resolves10.1017/S1355617720000296
Heterogeneous Response of Chemotherapy-Related Cognitive Decline in Patients with Breast Cancer: A Prospective Study
resolves10.1200/JCO.2011.38.5674
Alterations in Brain Activation During Working Memory Processing Associated With Breast Cancer and Treatment: A Prospective Functional Magnetic Resonance Imaging Study
resolves10.1016/j.bbi.2012.05.007
Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: A replication and extension study
resolves10.1002/hbm.21422
Late effects of high‐dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: Converging results from multimodal magnetic resonance imaging
resolves10.1016/j.critrevonc.2013.04.002
Late effects of adjuvant chemotherapy for adult onset non-CNS cancer; cognitive impairment, brain structure and risk of dementia
resolves10.1016/j.nbd.2012.07.009
Altered resting state functional brain network topology in chemotherapy-treated breast cancer survivors
resolves10.1200/JCO.2011.37.0189
Neuropsychological Performance in Survivors of Breast Cancer More Than 20 Years After Adjuvant Chemotherapy
resolves10.1007/s10549-017-4376-4
Executive functioning impairment in women treated with chemotherapy for breast cancer: a systematic review
resolves10.1371/journal.pone.0140655
Postoperative Structural Brain Changes and Cognitive Dysfunction in Patients with Breast Cancer
resolves10.1093/jnci/djz178
Trajectories of Cognitive Function Prior to Cancer Diagnosis: A Population-Based Study
resolves10.1016/j.jpainsymman.2015.06.019
Impact of Cancer and Its Treatments on Cognitive Function: Advances in Research From the Paris International Cognition and Cancer Task Force Symposium and Update Since 2012
resolves10.1002/pon.4009
Trajectories of self-reported cognitive function in postmenopausal women during adjuvant systemic therapy for breast cancer
resolves10.1080/13854046.2011.631586
Cognitive Effects of Chemotherapy-Induced Menopause in Breast Cancer
resolves10.1093/jnci/djv131
Inflammatory Biomarkers, Comorbidity, and Neurocognition in Women With Newly Diagnosed Breast Cancer
resolves10.1016/j.jneuroim.2016.11.002
Relationship of systemic cytokine concentrations to cognitive function over two years in women with early stage breast cancer
resolves10.3390/cancers11050687
Pretreatment Cancer-Related Cognitive Impairment—Mechanisms and Outlook
resolves10.1016/j.jpainsymman.2012.11.005
New Approaches to Understand Cognitive Changes Associated With Chemotherapy for Non-Central Nervous System Tumors
resolves10.3389/fnhum.2011.00122
Pre-Chemotherapy Differences in Visuospatial Working Memory in Breast Cancer Patients Compared to Controls: An fMRI Study
resolves10.1016/S0885-3924(01)00268-8
Cognitive Function and Reproductive Hormones in Adjuvant Therapy for Breast Cancer
resolves10.1016/j.neuroimage.2003.08.037
Estrogen- and tamoxifen-associated effects on brain structure and function
resolves10.1523/JNEUROSCI.0353-18.2018
Adverse Effects of Aromatase Inhibition on the Brain and Behavior in a Nonhuman Primate
resolves10.1016/j.yhbeh.2014.07.005
Decision-making impairments in breast cancer patients treated with tamoxifen
resolves10.1007/s10549-007-9556-1
An overview of prognostic factors for long-term survivors of breast cancer
resolves10.1080/13854049308401901
“<i>T</i>Scores for Change”: An illustration of a regression approach to depicting change in clinical neuropsychology
resolves10.1017/S1355617799544068
Detecting significant change in neuropsychological test
performance: A comparison of four models
resolves10.1037/0022-006X.59.1.12
Clinical significance: A statistical approach to defining meaningful change in psychotherapy research.
resolves10.1017/S1355617709990567
Predictors of Cognitive Decline After Chemotherapy in Breast Cancer Patients
The 1 reference without a DOI — listed, not checked
no DOI — not checkedCognitive functions in long‐term survivors of ovarian cancer
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1002/pon.5623"><img src="https://citestamp.com/citestamped/10.1002/pon.5623/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1002/pon.5623)